Preparation and MRI Study of HER2-Targeted Bimodal Molecular Probe Gd-Cy5.5-Pertuzumab for Thyroid Cancer

Table 1

Blood chemistry results of Sprague Dawley rats injected with Gd-Cy5.5-pertuzumab nanoparticles.

	ALT (U/l)	AST (U/l)	ALP (U/l)	BUN (mmol/l)	Cr (μmol/l)
Gd-Cy5.5-pertuzumab (n = 8)	52.50 ± 21.78	106.63 ± 24.47	219.50 ± 57.04	8.70 ± 2.27	35.38 ± 7.27
Control (n = 7)	57.14 ± 19.13	108.86 ± 20.19	215.43 ± 47.43	7.93 ± 1.14	32.29 ± 8.08
P	0.670	0.852	0.884	0.431	0.449